Pharmaceutical firms turn to high-priced new OTC products strategy

Pharmaceutical firms are now adopting to set up a higher pricing level on newly launched OTCs as a way to cope with poor sales of ethical products and co-existence of pharmacies instead of price hikes via increased doses of existing products including package modification.

Sources say that the high-priced OTC strategy is focusing on better sales record of both drug makers and pharmacies, as ...